Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCRISPR Therapeutics AG

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CRISPR Therapeutics AG

$54.03Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $10.18M. Net result −$91.15M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $10.18M. Running result $10.18M. Collaboration Revenue: $10M. Grant: $181K.
  • Cost of revenue: $0. Running result $10.18M.
  • Gross profit: $10.18M. Running result $10.18M.
  • Research and development: −$67.15M. Running result −$56.97M.
  • Acquired in-process research and development: −$2.47M. Running result −$59.44M.
  • General and administrative: −$17.55M. Running result −$77M.
  • Collaboration expense, net: −$40.27M. Running result −$117.27M.
  • Operating income: −$117.27M. Running result −$117.27M.
  • Other income: $27.08M. Running result −$90.19M.
  • Pre-tax loss: −$90.19M. Running result −$90.19M.
  • Income tax expense: −$960K. Running result −$91.15M.
  • Net loss: −$91.15M. Running result −$91.15M.